← Back to Search

Prevent Maternal Mortality using Mobile technology (PM3) for Postpartum

N/A
Waitlist Available
Led By Natalie Hernandez, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 3, month 6 and month 12
Awards & highlights

Study Summary

This trial is looking at using a mobile app to help improve postpartum care for black women in rural areas, who are at a higher risk for maternal morbidity and mortality.

Eligible Conditions
  • Postpartum

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 3, month 6 and month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 3, month 6 and month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of completion of postpartum healthcare visit ( Healthcare Resource utilization)
Secondary outcome measures
Adverse Childhood Experiences (ACEs) questionnaire
Appraisal of self-care agency Scale-Revised (ASAS-R)
Changes in Blood pressure
+15 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mother Using PM3 InterventionExperimental Treatment1 Intervention
Participants in this group will be using the PM3 intervention. PM3 is a maternal mortality prevention and optimal reproductive health promotion mobile app created based on formative work with Black women to ultimately increase postpartum comorbidity self-management, promote timely provider notification of postpartum-related complications, and ensure access to social support and community resources.
Group II: Mothers following Standard of CareActive Control1 Intervention
Participants randomized to this group will receive standard of Care for Postpartum. The standard of care control condition will be what women would typically get at hospital discharge (typically an Electronic Medical Record (EMR) generated document; a non-standardized, generalized brief review of how to care for self and the baby).

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,645 Previous Clinical Trials
2,564,250 Total Patients Enrolled
Natalie Hernandez, PhDPrincipal InvestigatorAssistant Professor
~95 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top